the aid library

LIST OPTIONS

Filter

3501

Progrès accomplis en matière de prévention et de maîtrise des maladies non transmissibles - Rapport du Secrétaire général

United Nations Secretary-General United Nations General Assembly (2017) C_WHO

Le document, intitulé « Progrès dans la prévention et le contrôle des maladies non transmissibles », rend compte des efforts mondiaux pour réduire l’impact des MNT (maladies non transmissibles), telles que les maladies cardiaques, le cancer, le diabète et les maladies respiratoires chroniq... more

External Link

Clinical Profile and Management of Patient Patients with Ischemic Heart Disease and/or Peripheral Artery Disease in Clinical Practice: The APALUSA Study

Barrios, V.; Escobar, C.; Suarez C. et al. Journal of Clinical Medicine (2022) CC

This study was aimed to ascertain the clinical profile and management of patients with ischemic heart disease (IHD) and/or peripheral artery disease (PAD). In this observational and cross-sectional study developed in 80 hospitals throughout Spain, consecutive adults with stable IHD and/or PAD were i... more

External Link

Disruption in essential health services in Mexico during COVID-19: an interrupted time series analysis of health information system data

Doubova SV, Leslie HH, Kruk ME, et al. BMJ Global Health (2021) CC

INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and outcomes in Mexico, describe observed and predicted trends in services over 24 months, and to estimat... more

Download (466)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

Promoting Cardiovascular Health in the Developing World

Institute of Medicine (2010) CC

Cardiovascular disease (CVD) is often thought to be a problem of wealthy, industrialized nations. The term “cardiovascular disease” is used throughout the report to refer to cardiac disease, vascular diseases of the brain and kidney, and peripheral vascular disease. The report’s main focus is ... more

Download (190)

View PDF (286)

Communicable and non-communicable diseases in Africa in 2021/22

World Health Organization Africa Region; WHO Africa World Health Organization Africa Region; WHO Africa (2023) C_WHO

This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra... more

HEARTS of NCD: An integrated approach to management of noncommunicable diseases in primary health care

World Health Organization WHO OpenWHO (2024) C_WHO

The course aims to cover the types of NCDs and risk factors, the challenges of delivering NCD services in primary health care, elements of WHO technical packages (PEN and HEARTS) for NCDs and how to adapt these packages in primary health care. SEARO NCD PEN-HEARTS is a series of four courses with... more

Download (670)

View PDF (892)

The Diabetic foot. Prevention and management in India. Quick Reference Guide (Draft)

National Health Mission; Ministry of Health & Social Welfare India (2016) C1

Standard Treatment Guideline

Download (726)

View PDF (1120)

The Diabetic foot. Prevention and management in India Full Background document (Draft)

National Health Mission; Ministry of Health & Social Welfare India (2016) C1

Standard Treatment Guideline

Download (397)

View PDF (690)

Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy

World Health Organization WHO (2013) C_WHO

New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999

Download (630)

View PDF (670)

Lineamientos técnicos para el abordaje integral, multidisciplinario e interinstitucional a las personas con pie diabético

José, F.; C G. Alvarenga Cardoza, K.M. Díaz de Naves Ministerio de Salud El Salvador (2021) C1

Technical guidelines for a comprehensive, multidisciplinary and inter-institutional approach to people with diabetic neuropathy

Download (688)

View PDF (1123)

Guidelines for Screening and Management of Diabetic Retinopathy

Ophthalmic Services Unit and the Division of Non Communicable Disease (DNCD), Ministry of Health Kenya (2017) C2

Download (597)

View PDF (535)

Dietary Guidelines for Indians

National Instiute for Nutrition, Indian Council for Medical Research (2011) C1

A Manual

Download (372)

View PDF (646)

Evaluation of the Free Diagnostics Scheme in Andhra Pradesh

Ministry of Health & Family Welfare, India World Health Organization WHO, India (2018) C_WHO

Download (1103)

View PDF (1117)

Namibia: Nutrition guidelines for prevention and management of non-communicable diet related disease

Ministry of Health and Social Services (MOHSS) (2013) C1

Download (853)

View PDF (1532)

WHO/ISH Cardiovascular Risk Prediction Charts for 14 WHO epidemiological sub-regions

World Health Organization WHO (2007) C_WHO

There are two sets of charts. One set (14 charts) can be used in settings where blood cholesterol can be measured. The other set (14 charts) is for settings in which blood cholesterol cannot be measured. Both sets are available in colour and shades of black on a compact disc. Each chart can only be ... more

Download (473)

View PDF (652)

Role in Prevention & Controle of Non-communicable Diseases (NCDs)

Ministry of Health & Family Welfare, India (2009) CC

Reading Material for ASHA no.8

External Link

Gesundheitsinformationen

Schweizerisches Rotes Kreuz (2020) C1

Broschüren, Ratgeber, Filme und Bildungsunterlagen in 56 Sprachen ansehen, herunterladen und online bestellen. Themen u.a. sind Schwangerschaft, Tuberkulose, Traumarbeit, Demenz, Herz-Kreislauferkrankungen

Download (454)

View PDF (486)

Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date

Carla Silva-Matos; David Beran (2012) C1

This revision covers the main non-communicable diseases in Mozambique as well as the National Strategic Plan's aim to create a positive environment to minimize or eliminate the exposure to risk factors and guarantee access to care.

Sa Heart Association Health Professionals Resources

SA Heart Association (2024) CC

Webinars, PDFs, Videos, papers in different topics e.g. adult congenital heart disease, aortic disease, atherosclerosis etc.